BACKGROUND AND PURPOSE: To determine the cytotoxicity of, and radioenhancement by, gemcitabine on a glioma cell line grown as a monolayer and as spheroid cultures. MATERIAL AND METHODS: We used a human glioma cell line, Gli-6, which originated from a biopsy specimen of a patient with a glioblastoma multiforme. Spheroids of Gli-6 were prepared by seeding a single cell suspension on agarose-coated Petri dishes. Clonogenic and growth delay assays were used to determine radio-chemosensitivity of monolayer cultures. The growth delay assay was used to determine that of Gli-6 spheroid cultures. RESULTS: Spheroid cultures were found to be more resistant to irradiation with/or without gemcitabine than monolayer cultures. Whereas gemcitabine significantly enhances the radiation effect of exponentially growing Gli-6 monolayer cultures at minimal cytotoxic concentrations (10 nM, 24 h), no enhancement was seen in confluent monolayer cultures and in large spheroids at the same concentration. In small spheroids no enhancement was observed at a low-dose gemcitabine (10 nM for 24 h), but an enhancement was observed at higher concentrations (100 nM for 24 h). CONCLUSION: Gemcitabine can lead to enhancement of the effects of X-irradiation in both monolayer as spheroid glioblastoma cultures. The lack of enhancement in confluent monolayer cultures supports the view that cell cycle distribution of cells is important in radiosensitisation by gemcitabine
BACKGROUND AND PURPOSE: To determine the cytotoxicity of, and radioenhancement by, gemcitabine on a glioma cell line grown as a monolayer and as spheroid cultures. MATERIAL AND METHODS: We used a humanglioma cell line, Gli-6, which originated from a biopsy specimen of a patient with a glioblastoma multiforme. Spheroids of Gli-6 were prepared by seeding a single cell suspension on agarose-coated Petri dishes. Clonogenic and growth delay assays were used to determine radio-chemosensitivity of monolayer cultures. The growth delay assay was used to determine that of Gli-6 spheroid cultures. RESULTS: Spheroid cultures were found to be more resistant to irradiation with/or without gemcitabine than monolayer cultures. Whereas gemcitabine significantly enhances the radiation effect of exponentially growing Gli-6 monolayer cultures at minimal cytotoxic concentrations (10 nM, 24 h), no enhancement was seen in confluent monolayer cultures and in large spheroids at the same concentration. In small spheroids no enhancement was observed at a low-dose gemcitabine (10 nM for 24 h), but an enhancement was observed at higher concentrations (100 nM for 24 h). CONCLUSION:Gemcitabine can lead to enhancement of the effects of X-irradiation in both monolayer as spheroid glioblastoma cultures. The lack of enhancement in confluent monolayer cultures supports the view that cell cycle distribution of cells is important in radiosensitisation by gemcitabine
Authors: M Weller; J Streffer; W Wick; R D Kortmann; E Heiss; W Küker; R Meyermann; J Dichgans; M Bamberg Journal: Cancer Date: 2001-01-15 Impact factor: 6.860
Authors: S Z Gertler; D MacDonald; M Goodyear; P Forsyth; D J Stewart; K Belanger; J Perry; D Fulton; W Steward; N Wainman; L Seymour Journal: Ann Oncol Date: 2000-03 Impact factor: 32.976
Authors: A Taghian; J Ramsay; J Allalunis-Turner; W Budach; D Gioioso; F Pardo; P Okunieff; N Bleehen; R Urtasun; H Suit Journal: Int J Radiat Oncol Biol Phys Date: 1993-01-15 Impact factor: 7.038
Authors: D Latz; K Fleckenstein; M Eble; J Blatter; M Wannenmacher; K J Weber Journal: Int J Radiat Oncol Biol Phys Date: 1998-07-01 Impact factor: 7.038
Authors: Chris van Bree; Natasja Castro Kreder; Willem J P Loves; Nicolaas A P Franken; Godefridus J Peters; Jaap Haveman Journal: Int J Radiat Oncol Biol Phys Date: 2002-09-01 Impact factor: 7.038
Authors: Hari R Kumar; Xiaoling Zhong; Derek J Hoelz; Frederick J Rescorla; Robert J Hickey; Linda H Malkas; John A Sandoval Journal: Pediatr Surg Int Date: 2008-09-17 Impact factor: 1.827
Authors: S M El Sayed; R M Abou El-Magd; Y Shishido; K Yorita; S P Chung; D H Tran; T Sakai; H Watanabe; S Kagami; K Fukui Journal: J Bioenerg Biomembr Date: 2012-07-17 Impact factor: 2.945
Authors: Bea Pauwels; Annelies E C Korst; Greet G O Pattyn; Hilde A J Lambrechts; Juliette A E Kamphuis; Christel M J De Pooter; Godefridus J Peters; Filip Lardon; Jan B Vermorken Journal: BMC Cancer Date: 2006-05-30 Impact factor: 4.430
Authors: Benedikt Kleineidam; Sonja Sielker; Marcel Hanisch; Johannes Kleinheinz; Susanne Jung Journal: Head Face Med Date: 2018-09-26 Impact factor: 2.151